Ichiro Nakashima
Ichiro Nakashima publishes mostly in Pathology and Forensic Medicine, Neurology and Immunology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Systemic Lupus Erythematosus Research.
- World rank
- #538,010 of 7,710,434 ranked researchers
- Rank in Japan
- #5,649 of 383,136
- Works
- 590
- Citations
- 23k
- Citations per work
- 39.6
What does Ichiro Nakashima research?
Ichiro Nakashima's work is mostly in Medicine (52%), Immunology and Microbiology (9%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences30952.4%
- Medicine30952.4%
- Everything else19032.2%
- Life Sciences9115.4%
- 1Pathology and Forensic Medicine22% of their works
- 2Neurology21% of their works
- 3Immunology9% of their works
- 4Molecular Biology6% of their works
- 5Rheumatology6% of their works
- 6Oncology3% of their works
Research topics
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Systemic Lupus Erythematosus Research
- Autoimmune Neurological Disorders and Treatments
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Neuroinflammation and Neurodegeneration Mechanisms
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Ichiro Nakashima's research?
The keywords of their largest research topics: Cognitive Impairment, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Neurological Disorders, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Guillain-Barré Syndrome and Autoantibodies.
- Fc Receptors
- Microglia
- Foxp3
- Dendritic Cells
- Anti-NMDA Receptor Encephalitis
- Systemic Lupus Erythematosus
- Autoantibodies
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Neuromyelitis Optica
- Diagnostic Criteria
- Cognitive Impairment
- Multiple Sclerosis
- Neurological Disorders
- Guillain-Barré Syndrome
- Antiphospholipid Syndrome
- Innate Immunity
- Paraneoplastic Syndromes
- Immunity
- TGF-ß
- Neuroinflammation
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cognitive Impairment3802 topics
- Diagnostic Criteria3802 topics
- Multiple Sclerosis3261 topic
- Neuromyelitis Optica3261 topic
- Neurological Disorders2622 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy2081 topic
- Guillain-Barré Syndrome2081 topic
- Autoantibodies1212 topics
- Antiphospholipid Syndrome671 topic
- Systemic Lupus Erythematosus671 topic
- Innate Immunity552 topics
- Anti-NMDA Receptor Encephalitis541 topic
- Paraneoplastic Syndromes541 topic
- Dendritic Cells301 topic
- Immunity301 topic
- Foxp3291 topic
- TGF-ß291 topic
- Microglia251 topic
- Neuroinflammation251 topic
- Fc Receptors231 topic
- Therapeutic Antibodies231 topic
Where does Ichiro Nakashima work?
Ichiro Nakashima's main affiliation in the publication record is Tohoku University, Japan.
How many publications and citations does Ichiro Nakashima have?
OpenAlex counts 590 works and 23,375 citations for Ichiro Nakashima, an h-index of 71, ranking #538,010 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ichiro Nakashima. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.